NA Proactive news snapshot: BioHarvest Sciences, Marble Financial, ElectraMeccanica Vehicles, Ion Energy UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
BioHarvest Sciences Inc. (CSE:BHSC) (FRA:8MV) has announced the launch of direct-to-consumer sales of its flagship product VINIA in the United States, via its vinia.com website. After years of developing its BioFarming technology, the company said it is proud to bring the first product based on this technology to the US market. VINIA is the first and only product in the world containing Piceid Resveratrol from red grapes at levels in each 400mg capsule of VINIA equivalent to an average bottle of red wine, providing the benefits of red wine with the advantage of zero calories, zero sugar and zero percent alcohol. BioHarvest said the successful launch of VINIA in Israel has provided the company with experience in
Share:
ISELIN, N.J., May 12, 2021 (GLOBE NEWSWIRE) Outlook Therapeutics, Inc. (NASDAQ:OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced it will host a Virtual Clinical Day for analysts and accredited institutional investors with live video webcast (details below) on Thursday, May 20, 2021 from 11:00 AM – 1:00 PM ET.
During the Virtual Clinical Day, Outlook Therapeutics will provide an overview of its lead program, ONS-5010 / LYTENAVA™ (bevacizumab-vikg), its investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration (wet AMD), its ongoing Phase 3 study in wet AMD, NORSE TWO, and its plans for a potential commercial rollout.